Di Nolfo 2017 MiPschool Obergurgl
From Bioblast
Revision as of 10:41, 18 July 2017 by Kandolf Georg (talk | contribs) (Created page with "{{Abstract |title=left|60px|link=http://www.mitoglobal.org/index.php/MITOEAGLE|COST Action MITOEAGLE |info=MITOEAGLE |year=2017 |even...")
 |
Link: MITOEAGLE
(2017)
Event: MiPschool Obergurgl 2017
Labels:
Affiliations
- (1)
References
- Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, Puffenberger EG, Hamosh A, Nanthakumar EJ, Curristin SM et al. (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352:337–9.
- Gelb BD (2006) Marfan's syndrome and related disorders—more tightly connected than we thought. N Engl J Med 355:841–4.
- Judge DP, Dietz HC (2005) Marfan's syndrome. Lancet 366:1965-76.
- Keane MG, Pyeritz RE (2008) Medical management of Marfan syndrome. Circulation 117:2802–13.
- Morse RP, Rockenmacher S, Pyeritz RE, Sanders SP, Bieber FR, Lin A, et al. (1990) Diagnosis and management of infantile Marfan syndrome. Pediatrics 86:888–95.
- Geva T, Sanders SP, Diogenes MS, Rockenmacher S, Van Praagh R (1990) Two dimensional and Doppler echocardiographic and pathologic characteristics of the infantile Marfan syndrome. Am J Cardiol 65:1230–7.
- Ramachandra CJ, Mehta A, Guo KW, Wong P, Tan JL, Shim W (2015) Molecular pathogenesis of Marfan syndrome. Int J Cardiol 187:585-91.
- Radke RM, Baumgartner H (2014) Diagnosis and treatment of Marfan syndrome: an update. Heart 100:1382–91.
- Sakai LY, Keene DR, Engvall E (1986) Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 103:2499–2509.
- Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, van Erp C, et al. (2011) Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332:358–61.
